Jiaming Zhu

METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1

Zhihui Lu, Hong Liu, Nana Song et al. · Cell Death and Disease · 2021 · 115 citations · Full text

Medicine, Molecular Biology, Nephrology +17

The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration

Xiaofang Yu, Yi Fang, Hong Liu et al. · Nephrology Dialysis Transplantation · 2012 · 84 citations

Medicine, Nephrology, Pharmacology +16

A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor

Tianzhou Liu, Dawei Zhang, Wantong Song et al. · Acta Biomaterialia · 2017 · 81 citations

Medicine, Oncology, Pharmacology +13

miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer

Dacheng Wen, Songhe Li, Fujian Ji et al. · Tumor Biology · 2013 · 64 citations

Medicine, Cancer Biology, Oncology +17

miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1

Xiangfu Ding, Jingjing Liu, Tianzhou Liu et al. · Cancer Medicine · 2017 · 62 citations · Full text

Medicine, Cancer Biology, Oncology +17